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a b s t r a c t 
The vortex flow reactor (VFR) can be used in many chemical engineering applications. This paper assesses 
its novel use in the purification of monoclonal antibodies from cell broth. To this end, the IgG2a antibody 
was purified from the unclarified fermentation broth of transgenic mouse 55/6 hybridoma cells. Visual 
experiments showed that the VFR worked in the laminar vortices flow regime and the vortices displaced 
slightly faster than the axial flow. The VFR has the advantage of creating two sorts of flows: axial flow to 
produce the expanded bed and an extra vortex flow to avoid channeling and stabilize the expanded bed, 
the hydrodynamic behavior of which is plug flow with an experimental Pèclet number higher than 20. 
The pH was adjusted in the untreated fermentation broth, which was directly introduced into the reactor 
thus reducing the number of stages. The IgG2a purification was carried out in a single device via two 
steps: antibody adsorption in the expanded bed and antibody elution in the settled bed using Streamline 
rProtein A. A thirty-fold increase in the high-purity antibody concentration was achieved at the top of 
the pH5 elution peak with a total recovery of 93.1% (w/w) between elution peaks pH 5 and 3. 









































The VFR is a promising technology in the chemical engineering 
nd biotechnology field. Its hydrodynamic behavior, such as plug 
ow or well mixing, along with enhanced mass transfer, makes it 
uitable for a wide variety of applications including heat exchange 
1] , polymerization [ 2 , 3 ], particle classification [4] , photocatalysis 
 5 , 6 ], reverse osmosis [7] , enzymatic reactions [ 8 , 9 ], cell cultivation
 10 , 11 ] and protein purification [ 12 , 13 ]. 
The VFR is made up of a stationary outer cylinder and a ro- 
ating inner cylinder. The low-speed rotational movement of the 
nner cylinder creates a Couette flow. When the rate surpasses a 
ritical rotation speed, the bifurcation of the flow creates a series 
f counter-rotating toroidal vortices identified as Taylor vortices, 
hich occupy the inner cylinder in the form of stacked “donuts”
14] . Each vortex has a characteristic size along the z-axis of ap- 
roximately the gap width between the cylinders. Increasing the 
otation rate, different flow patterns appear - from laminar, wavy, 
nd turbulent vortex flow to turbulent flow with no vortices. This 
lso occurs when changing the hydrodynamic behavior from plug 
ow to well mixing [ 15 , 16 ]. ∗ Corresponding author. 





021-9673/© 2021 Published by Elsevier B.V. The use of VFRs for protein adsorption began with Moore and 
ooney [17] and Ma and Cooney [12] Both had to deal with flow 
lockages in the reactor outlet due to the presence of the resin. 
a worked at a high rotation rate causing fluidized adsorbent par- 
icles to exit the vortices, hence the need to introduce a mesh and 
ncrease the outlet area to decrease the axial velocity and keep the 
articles inside the reactor. They found that the main reason for 
his was that the particles were suspended by the vortices instead 
f by the axial flow. 
The nylon mesh that produces the resin blockage was removed 
rom the outlet when changing the vortex flow reactor operat- 
ng conditions [18] . The adsorbent resin is suspended in the ax- 
al flow while regulated by the vortex flow. The VFR behavior is 
imilar to that of a fluidized bed but, in this case, the inner cylin- 
er’s rotation speed can be varied independently of the axial ve- 
ocity, introducing an additional degree of freedom to the system. 
his configuration thus provides a sound basis for using the vor- 
ex flow reactor as an expanded bed chromatography method that 
s suitable for biomolecule purification [13] . In that research study, 
he intracellular biomolecule B-phycoerythrin was purified from a 
oncentrated extract consisting of disrupted Porphyridium cruentum 
ells. 
The main objective of this work is to assess the potential use of 
he VFR in purifying monoclonal antibodies, directly from the cell 
roth, thus avoiding pretreatments. 



























































Geometric dimensions of the EB-VFR. 
r o (outer cylinder radius), cm 0.95 
r i (inner cylinder radius), cm 0.50 
η (radius ratio, r i /r o ) 0.526 
d (annular gap width, r o -r i ), cm 0.45 
d/r i 0.90 
L (height of the outer cylinder) cm 95 
S (gap area), cm 2 2.05 
H (expanded bed height) 47-56 










































The demand for monoclonal antibodies is steadily increasing 
ue to their great potential in therapeutic and diagnostic appli- 
ations. The global market for therapeutic monoclonal antibodies 
as valued at $ 115.2 billion in 2018; it is projected to reach $ 300
illion in 2025 [19] . The monoclonal antibody trade accounts for 
ore than 50% of the total biotech market. 
Therefore, monoclonals are a very good example of bulk prod- 
cts that have to be purified efficiently to make their production 
conomically competitive. For this reason, it is important to de- 
elop less expensive antibody purification processes with shorter 
xecution times [20] . 
Using chromatography with Protein A as the adsorbent has tra- 
itionally been the most suitable alternative for antibody purifi- 
ation. Currently, research is being carried out to optimize this 
ethod, such as that by D’Souza et al. [21] , who studied the 
ost appropriate mobile phase for reducing biomass fouling in ex- 
anded bed adsorption. Given Protein A’s high cost and limited 
helf life, other authors, such as Zhang et al. [22] , focused on re-
ucing the cost of the resin in the overall purification set up by 
aximizing its functional lifetime. A multitude of antibody purifi- 
ation systems have been developed, many of which attempt to au- 
omate the antibody purification process, decrease the processing 
ime and work with up to five samples in parallel [23–26] . Some 
f the new methods developed for monoclonal antibody purifica- 
ion are based on precipitation with anionic polyelectrolytes [27] , 
queous two-phase systems [28–30] or phenylboronic acid chro- 
atography [31] . Nonetheless, all these works have one common 
haracteristic, the need to include a prior sample preparation step. 
he samples must be clarified, either by filtration or by centrifuga- 
ion, before being introduced into the purification system. 
The novelty of this research is to apply VFR to the purifica- 
ion of antibodies (as extracellular biomolecules) using Protein A. 
his equipment provides several benefits when used with classical 
hromatography: on the one hand, the purification is carried out in 
wo stages (adsorption and elution) and on the other, the samples 
o not require clarification as they can be introduced directly into 
he reactor. Therefore, not only is the processing time reduced, but 
lso the cost and complexity of the process. The proposed system 
eeks to maintain the benefits of Protein A chromatography and 
mprove its shortcomings by using a single device. 
To achieve the main objective of this work, an expanded bed 
ortex flow reactor (EB-VFR) was designed, built, and tested for 
he adsorption and purification of monoclonal antibodies from an 
nclarified culture broth. The EB-VFR was applied to the recovery 
f IgG2a from untreated transgenic mouse 55/6 hybridoma fermen- 
ation broth. In this case, it was necessary to design a smaller VFR 
han those used in previous experiments [13] ; to do this, the an- 
ular gap was kept constant at 0.45 cm by reducing the diameters 
f the inner and outer cylinders. 
. Experimental 
.1. Cell culture 
Mouse hybridoma cells designated 55-6 (ATCC CRL-2156), 
hich produce immunoglobulin G subclass 2 ª (IgG2a), were 
ultivated in PFHM II culture medium (Gibco®) without fetal 
ovine serum (FBS), supplemented with 100U/mL of penicillin- 
treptomycin (Gibco®) and 0.125 g/mL of amphotericin B (Gibco®). 
o isolate the IgG2a in the VFR, batch cultures were performed 
n a 0.6 L stirred-tank reactor (STR) containing 0.4 L of cell cul- 
ure medium (Biostat Q, B. BRAUN, Germany). The temperature 
as controlled at 37 °C. The dissolved oxygen concentration was 
aintained at 50% air saturation by adjusting the air/O 2 /N 2 ratio 
f the inlet gas. Surface aeration was set to a constant 0.1 L/min 
o maintain a cell concentration up to 5 × 10 6 cells/mL, reaching 2 aximum growth rates between 0.018 and 0.034 h −1 . The anti- 
ody concentration in the culture broth at the end of the fermenta- 
ion process was maintained at around 32.50 μg IgG2a/mL in batch 
ode. 
.2. The EB-VFR design 
Fig. 1 shows the EB-VFR used in this work. The main body of 
he reactor is formed by an outer cylinder of transparent acrylic 
aterial (1) which remains static, and an inner steel cylinder (2), 
oth of which are conFig.d concentrically. The inner cylinder ro- 
ates at a variable speed depending on the set points assigned to 
he motor (3) (Heidolph RZR 2102 control Z); its rotation range 
aries from 0 to 75 rpm. Both cylinders are attached at the base by 
 bearing that allows the inner cylinder to rotate. The output ports 
4) are located along the length of the outer cylinder wall, with a 
istance between each of 2 cm. In addition, 2 mm above the reac- 
or base on the right side is the liquid feed inlet used during the 
dsorption process (5), and on the left side, the elution fluid out- 
et (7), over which a nylon mesh is placed to prevent the escape 
f the adsorbent material. At the bottom of the reactor, there is an 
utlet port for removing the adsorption resin (6). Two peristaltic 
umps (Minipuls3, Gilson, Middleton, USA) are used to pump the 
iquid flow. The VFR dimensions are shown in Table 1 . 
.3. The adsorbent 
The adsorbent used was Streamline rProtein A (GE Healthcare, 
ppsala, Sweden) which is an affinity adsorbent consisting of a 
omposite material of cross-linked agarose and steel beads with 
 particle size distribution of 80-165 μm (123 μm average particle 
ize). The mean particle density was 1300 kg/m 3 . 
.4. Qualitative determination of monoclonal antibodies 
A Mouse Immunoglobulin Isotyping ELISA Kit (Thermo Scien- 
ific, Rockford, USA) containing mouse IgG 1 , IgG 2a , IgG 2b , IgG 3 , IgA,
gM and kappa and lambda light chains was used for class and 
ubclass determination of the monoclonal antibodies in the cell 
ulture. This kit uses ELISA plates with wells pre-coated with spe- 
ific anti-mouse capture antibodies, which allows one to discern 
gG 1 , IgG 2a , IgG 2b , IgG 3 , IgA, IgM, and between kappa or lambda
ight chains. The steps were followed as per the manufacturer’s in- 
tructions. 
.5. Determination of antibody concentration 
The IgG2a concentration in the cell culture, and the adsorption 
nd wash fractions during the purification process, were measured 
ith the sandwich-type ELISA quantitation set (Bethyl Laboratories, 
ontgomery, USA) using goat anti-mouse IgG-coated plates and 
oat anti-mouse IgG peroxidase conjugate as the second antibody. 
he steps followed and the reagents used were those provided in 
R.M. Rosa M, I.G. María J, M.S. Tania et al. Journal of Chromatography A 1655 (2021) 462502 
Fig. 1. Representation and description of the vortex flow reactor in both phases (a) adsorption with expanded resin, EB-VFR, and (b) elution with settled resin, VFR. (1) clear 
acrylic outer cylinder, (2) stainless steel inner cylinder, (3) variable speed motor, (4) outlet ports, (5) liquid feed inlet in the adsorption phase, (6) outlet port for removing 





































c  he manufacturer’s manual. The IgG2a concentration in the elu- 
ion fractions was calculated by UV adsorption at 280 nm (Jasco 
-630, Tokyo, Japan) using a standard curve with standard IgG2a 
Bethyl Laboratories, Montgomery, USA). The yield was determined 
s the loaded antibody percentage that eluted in the purified 
ractions. 
.6. Visualization experiments 
Two kinds of visual experiments were performed using pearl 
ica powder with metal oxides (ferric oxide and titanium dioxide). 
he particle size distribution was between 10 and 60 μm and the 
article mean density was 2600 kg/m 3 . 
Firstly, the silver pearl mica powder in aqueous suspension (1%) 
as used to visualize the vortex flow reactor’s flow regime at a 
ow rate of 300 cm/h (10.2 mL/min) and at different rotation rates 
etween 20 and 75 rpm. The suspended particles were mixed be- 
ore being introduced continuously into the VFR’s bottom inlet un- 
il stationary conditions were reached at each rotation rate. The 
uspended particles exited via the outlet port located around 47 
m from the VFR base. 
Secondly, a water flow was introduced continuously via the 
FR’s bottom inlet, which exited via the same outlet port located 
7 cm from the bottom of the VFR. After reaching VFR stationary 3 onditions at 300 cm/h, and at different rotation rates between 35 
nd 75 rpm, 1 mL of red pearl mica in aqueous suspension (1%) 
as injected by syringe into the port located at a height of 29 cm. 
sing a ruler situated in the VFR outer cylinder and a timer, it was 
ossible to measure the vortices-pair velocity visualized by the red 
ica powder. Each assay was performed three times. 
.7. Residence time distribution (RTD) 
To determine the RTD, the tracer was introduced in steps via 
he EB-VFR’s bottom inlet. The detection of the tracer signal at the 
eactor outlet determined the RTD of the EB-VFR under the set 
onditions. The detection was performed by UV absorption set at 
80 nm using a spectrophotometer with a flow cell (V630, Jasco, 
aryland, USA). The settled bed adsorbent height (Streamline rPro- 
ein A) in the annular space was 20 cm (50 mL) and the axial flow
ate was 300 cm/h (10.2 mL/min). The expanded bed height was 
7 cm. 
The residence time distribution (RTD) assays [32] are used to 
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2 , where C i = C i − C i −1 . C i , C i-1 and C max are the tracer con- 
entrations in the VFR outlet at the times t , t and t n , respec-i i-1 









































































































ively. The residence time distribution (T, min) is defined as T = 
n ∑ 
=1 
t i · C i / C max . 
The Péclet number is the ratio of convective to diffusive mass 
ransport, defined as Pe = U ·H/ ε·D ax , where U is the superficial ve-
ocity (m/s), H is the height of the expanded bed (m), ε is the bed
oidage and D ax is the coefficient of axial mixing (m 
2 /s). The Pé- 
let number (Pe) and the axial dispersion (D ax , m 
2 /s) were calcu- 
ated from the RTD assays [33] , as explained in the bibliography 
13] . 
RTD analyses were carried out in triplicate at EB-VFR rotation 
ates of 20, 35, 50 and 75 rpm for rProtein A. Also, an RTD analysis
as carried out at 40 rpm and 300 cm/h with no adsorbent, so 
hat the VFR was filled up to a height of 47 cm with water only.
he error was calculated as the standard deviation of the triplicate 
ssays. 
.8. Frontal chromatography in the expanded bed column 
A 0.5 cm column was packed with 1 mL of Streamline rPro- 
ein A adsorbent and was further equilibrated with 200 mM of 
otassium phosphate buffer at pH 7.5. The hybridoma fermenta- 
ion broth was clarified by centrifugation (10 0 0 0 g) and microfil- 
ration (0.45 μm). A 250 mL volume of particle-free solution was 
djusted to the pH of the 200 mM sodium phosphate equilibration 
uffer (pH 7.5) and applied to the column in the expanded bed 
t an axial flow rate of 300 cm/h. After sample application, the 
xpanded bed was washed with equilibration buffer until no pro- 
eins were detected in the column outlet. The bound antibody was 
luted in the same column at an axial flow rate of 150 cm/h with
00 mM sodium citrate buffer at different continuous pH values, 
tarting at pH 6 and finishing at pH 3. Finally, adsorbent genera- 
ion was performed using 2 column volumes of 2 M urea and 2 
olumn volumes of 1 M acetic acid. 
.9. Viscosity measurement of the cell culture 
A rotational viscometer (Brookfield DV-II + Pro Viscometer, LVF 
ode, spindle ULA-DIN-85, Middleboro, MA, USA) was used to an- 
lyze the rheological parameter of the cell culture. 
The experimental values of the shear rate and shear stress data 
ere fitted into the mathematical model, the Power Law, to give 
he flow behavioral index as τ = K · γ n , where τ is the shear stress 
Pa), K is the consistency index (Pa ·s), γ is the shear rate (s −1 ) and
 is the flow behavior index (dimensionless). When the value of n 
s equal to 1, the fluid is Newtonian, whereas it is non-Newtonian 
hen n is different from 1. A rotation interval between 50-90 rpm 
as used with increments of 10 rpm. All samples were analyzed 
n duplicate at room temperature. 
.10. Purification process in the vortex flow reactor 
Fig. 3 shows the flowchart of the IgG2a purification, which in- 
olved the following steps: mixing the culture with sodium phos- 
hate, adsorption in the EB-VFR, and IgG2a elution in the packed- 
ed VFR. 
The annular space of the vortex flow reactor was filled with 20 
m (50 mL) of Streamline rProtein A adsorbent, which was equili- 
rated in the upward flow with 200 mM of sodium phosphate, at 
H 7.5, and at 300 cm/h (10.2 mL/min). During the equilibration 
tage, the rotation rate was set at 50 rpm. The equilibration was 
erformed until the expanded bed appeared to be optically stable 
t an expanded bed height of 47 cm. Later, the pH of the culture 
50 0 0 mL, kept frozen at -19 °C until use) was adjusted to 7.5 us-
ng sodium phosphate and then introduced into the reactor with 
he same linear flow rate as the equilibration buffer. The expanded 4 ed height increased to 54 cm ( Fig. 1 a and Fig. 3 , step 3). The ef-
uent was gathered in fractions by means of a RediFrac fraction 
ollector (GE Healthcare, Uppsala, Sweden) so that it could be col- 
ected in small fractions of a determined volume. The rotation rate 
f the inner cylinder was 50 rpm. 
During the feed application, only the IgG2a antibody was ad- 
orbed into the Streamline rProtein A due to its specificity. Other 
roteins from the culture medium and the hybridoma cells were 
luted. The adsorption process lasted 8 hours. After the feed appli- 
ation, the expanded bed located in the annular space was washed 
ith equilibration buffer until no contaminants could be detected 
n the outlet flow. Next, the bed was settled in the annular space, 
nd the elution was carried out in packed-bed mode at an axial 
elocity of 100 cm/h ( Fig. 1 b and Fig. 3 , step 4). The bound IgG2a
as eluted with 100 mM sodium citrate buffer at pH 5. Lastly, the 
emaining adsorbed IgG2a was completely eluted with 100 mM 
odium citrate at pH 3. The eluted fractions were then gathered 
n tubes containing 1 mL Tris-HCl at pH 8 for direct neutralization. 
he resin was regenerated by applying 2 column volumes of 2 M 
rea and 2 column volumes of 1 M acetic acid. 
. Results and discussion 
.1. Flow regime 
Visualization experiments to determine the flow regime and the 
ortex drift velocity were performed with pearl mica particles at 
00 cm/h. Stokes’ law was used to calculate the mica particle size, 
he terminal velocity of which is equal to the axial flow rate. A 
alue of 31 μm was obtained. Therefore, pearl mica particles of 
ess than 31 μm are dragged along with the axial flow while those 
reater than 31 μm are fluidized (for flow regime experiments) 
r go down to their fluidization height (for drift velocity experi- 
ents). 
Visualization experiments with the silver pearl mica in aqueous 
uspension (1%) at 300 cm/h were performed at 20, 50 and 75 rpm 
o observe the laminar Couette and laminar vortex flow regimes 
 Fig. 2 ). The pearl mica is made up of anisotropic reflective par- 
icles, so with this technique one could easily observe the vortex 
ow formation throughout the vortex flow reactor. One could also 
bserve the vortex’s outflow and inflow boundaries. The boundary 
etween the two vortices moves faster when their outflow bound- 
ries are joined [15] , allowing one to see them ( Fig. 2 b, c and d),
ut it moves slower when their inflow boundaries are joined [15] ; 
hen, it is not possible to visualize them. Hence, a unit is formed 
y a pair of vortices located between two outflow boundaries. In 
act, the unit length could be visually measured, the value being 
round 0.9 cm ( Fig. 2 d), twice the size of the vortex or annular
ap. 
The Taylor numbers were estimated for the rotation rate range 
sing the following equation: Ta = ( ω·r i ·d)/ ν , where ω is the an-
ular velocity, r i is the inner cylinder radius (m), d is the annular 
ap (cm), and ν is the kinematic viscosity (m 2 /s). The results are 
hown in Table 2 . 
The critical Ta number [7] for producing vortices, Ta c , can be 
stimated using Eq. (1) : 
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(1) 
For the VFR configuration used in this work, the corresponding 
ritical Taylor number was 69. 
To normalize the rotation rate effect as a function of the VFR’s 
eometry and the fluid’s physical properties, the Ta/Ta c ratio was 
alculated ( Table 2 ). 
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Fig. 2. Visualization experiments made with silver pearl mica (1% w/w) in aqueous suspension at 300 cm/h. a) 20 rpm, laminar Couette flow b) 35 rpm, laminar vortex flow 
c) 50 rpm, laminar vortex flow and d) 75 rpm, laminar vortex flow. 
Table 2 
RTD study results, mass transfer values and regime behavior in the EB-VFR for various rotation rates at 300 
cm/h and an expanded bed height (or water height) of 47 cm. 
rpm Regime ∗ Adsorbent Ta Ta/Ta c D ax (m 2 /s) Pe T (min) K mf ∗∗ (m/s) 
20 C r ProteinA 49 0.7 1.2 ·10 −5 ±1 ·10 −6 44 ±4 12.3 3.5 ·10 −7 
35 T r ProteinA 83 1.2 1.2 ·10 −5 ±1 ·10 −6 44 ±1 12.4 4.2 ·10 −7 
50 T r ProteinA 117 1.7 1.4 ·10 −5 ±3 ·10 −6 42 ±6 12.3 4.8 ·10 −7 
75 T r ProteinA 177 2.5 1.6 ·10 −5 ±3 ·10 −6 30 ±6 12.7 5.5 ·10 −7 
40 T no resin 94 1.4 7.1 ·10 −6 ±3 ·10 −7 55 ±4 14.4 4.0 ·10 −7 
∗Regime behavior: Couette flow (C), Taylor flow (T). 















































At 20 rpm (Ta/Tac = 0.7), the laminar Couette flow is super- 
mposed on the axial flow in the annulus; this is also called the 
ouette-Poiseuille flow ( Fig. 2 a). 
Above 35 rpm, the experiments were conducted in the laminar 
ortices flow regime, where Ta < 15 ·Ta c [34] ( Fig. 2 b, 2 c and 2 d).
n this regime, the laminar vortices move upstream with the ax- 
al flow. The Reynolds number was calculated as detailed in the 
ibliography [13] , having a value of 5.5 at 300 cm/h. According to 
iordano et al. [15] , the presence of an axial flow could induce 
 delay in the vortices onset. However, in our work, this effect 
as negligible for a Reynolds number of 5.5. Likewise, Lueptow 
t al. [35] found that laminar vortices appear unaffected up to a 
eynolds number of 9. 
The vortex drift velocity is defined as the unit core speed di- 
ided by the bulk axial flow rate. In this work, the unit’s relative 
peed was measured for all the rotation rates (35-75 rpm) using 
ed pearl mica suspension (1%) injected into the unit (a pair of 
ortices). The smaller red pearl particles (less than 31 μm) move 
nside the unit, making it easier to measure the speed of the pair 
f vortices, whereas the particles greater than 31 μm drop to the 
ottom. The drift velocity was calculated as 1.2 ±0.1 (a radius ratio 
f 0.53), so the continuous units displace slightly faster than the 
xial flow velocity in the laminar vortex flow regime; this is in ac- 
ordance with the visual flow regime experiments. Furthermore, in 
he bibliography on the laminar vortex flow regime, the drift ve- 
ocity tends to be around 1.2 for a radius ratio of 0.95 [36] , or be-
ween 1 and 1.4 for a radius ratio of 0.85 [35] . In addition, the drift5 elocity increased when the flow regime changed to a helical vor- 
ex flow by increasing the rotation rate (1.5-1.8) [35] . The transition 
rom a laminar to a helical vortices regime for a radius ratio of 0.5 
similar to our VFR) would occur with an axial Reynolds number 
bove 24 [35] . This confirms the laminar vortex flow regime in our 
FR, operating at a Reynolds number of 5.5 and Ta/Tac ratios be- 
ow 2.5. 
.2. Expanded bed characteristics in the EB-VFR 
In accordance with the bibliography [13] , the experiments were 
onducted at a constant flow rate of 300 cm/h between the mini- 
um and terminal fluidization velocities using Streamline rProtein 
. 
The terminal fluidization velocity, u t , for the smallest beads can 
e estimated using Stokes’ law as having a value of 364 cm/h. The 
inimum fluidizing velocity, u mf , is calculated using the Levenspiel 
q. [37] , giving a value of 9.7 cm/h. 
At 300 cm/h, the expanded bed’s height was always 47 cm. 
t low rotation rates of between 35 and 75 rpm (Talt;3 ·Ta c ), 
he particle suspension was primarily generated by axial flow 
Re = 5.5) rather than by the rotation rate (Ta between 83 and 
77). Hence, the expanded bed height only depends on the ax- 
al velocity. The same VFR behavior was found in the bibliogra- 
hy in reference to hydrodynamic studies focused on purifying BSA 
18] and B-phycoerythrin from a concentrated extract of disrupted 
ells [13] . 
























































































































From the adsorbent mass balance between the settled and ex- 
anded bed height, and assuming that the settled bed porosity is 
.4, an expanded bed porosity of 0.75 was determined. 
.3. RTD, fluid dynamics and mass transfer in the EB-FVR 
The RTD studies were calculated experimentally for a range of 
ow operating rotation rates (20-75 rpm) at a constant expanded 
ed height (47 cm) and axial velocity (300 cm/h) to explore the 
ydrodynamic behavior of the EB-FVR using Streamline rProtein A 
50 mL). 
Table 2 also shows the Péclet number, which is a measure of 
he overall axial dispersion and thus indicative of the flow through 
he system as either plug flow or well-mixed, giving a clear idea 
f the EB-VFR’s hydrodynamic behavior in terms of antibody ad- 
orption. The vortices’ width was approximately 0.45 cm for this 
B-VFR design, corresponding to the annular space. Based on the 
ed height and vortex height, one can estimate that there were 
04 vortices. Knowing that a pair of vortices behaves as a mixed 
ank, and that their size is approximately twice that of the annular 
ap [34] , there were 52 continuous mixed tanks inside the annu- 
ar zone, so plug flow can be assumed. When the value of Pe > 20,
here is plug flow through the expanded bed, and thus it behaves 
ike a packed bed [38] . 
The EB-VFR behaved as a plug flow reactor at low rotation rates 
35 - 75 rpm) and the Pe number was similar, at around 44, for 
a/Tac values close to 1 (between 0.7 and 1.7). The Péclet number 
egan to decrease as the rotation rate increased, with Ta/Tac values 
reater than 1.7. This accords with the findings of Ma and Cooney 
12] for Streamline DEAE, where they reported that an increased 
otation rate increases the turbulence within and between vortices 
o that it is detrimental to the plug flow regime. In Table 2 , one
an also see that the axial dispersion coefficient (D ax , m 
2 /s) at 300
m/h was not very sensitive to changes in the low rotation rate 
ange. Within the Taylor vortex flow regime (0 < Ta/Tac < 15), the ax- 
al dispersion coefficient was slightly higher than 1 × 10 −5 (m 2 /s), 
uggesting that the expanded bed vortex flow reactor should be 
nstable, as predicted for an expanded bed column [39] . However, 
he vortices stabilize the expanded bed and can be used success- 
ully, thus providing the best operating conditions for Ta/Tac values 
etween 1.2 and 1.7. 
Observations from another research work [40] suggest that ax- 
al dispersion falls to a minimum close to the onset of Taylor vor- 
ices and rises along with increasing Taylor numbers (Ta). In that 
esearch paper, with rotation rates between 20 rpm and 35 rpm, 
he dynamic fluid was almost the same, with a Pe number of 44. 
owever, the flow regimes were totally different because at 20 
pm, the laminar Couette flow was present, while at 35 rpm, the 
aminar vortices regime flow was observed ( Fig. 2 ). Due to the 
resence of the vortices, the external mass transfer was higher 
n the laminar vortex flow regime than in the laminar Couette 
ow regime; accordingly, the adsorption process was carried out 
bove Ta c . The external mass transfer (k mf , m/s) for each rotation 
ate was also determined ( Table 2 ) using Moore’s correlation [41] , 
hich has been explained in detail by Ibáñez and Cooney [18] . In 
his case, the molecular weight of the IgG2a (150 0 0 0 Da) was used
o calculate the molecular diffusion coefficient (D m ), the value be- 
ng 4.1 ·10 −11 m 2 /s. 
As shown in Table 2 , the external mass transfer increased with 
ncreased rotation. This was also due to the unit’s increasing out- 
ow boundary speed - the faster it was, the thinner the outflow 
oundaries [15] ( Fig. 2 ). Table 2 also indicates that, when the ax-
al rate is kept constant, the RTD (T, min) does not depend on the 
otation rate, irrespective of the flow regime. 
On the other hand, when there is no resin, the tracer must 
ravel further, and the residence time increases ( Table 2 ). Further- 6 ore, the absence of resin increases the Pèclet number up to 55 
at 40 rpm). The adsorbent particles in the expanded bed disFig. 
he outflow boundaries between the vortices-pair units, increasing 
he axial mixing (a Pèclet number between 42 and 44). During the 
TD analysis or the adsorption step in the expanded bed ( Fig. 1 a or
ig. 3 , step 3), it is not possible to visualize the vortices pairs be-
ause the rProtein A beads are not anisotropic reflective particles. 
owever, Giordano et al. [15] concluded that no matter the kind of 
articles, the flow pattern remained the same. 
Comparing the Pe number reported in this paper to those re- 
orted in the bibliography [13] with the same Ta/Ta c ratio of 2.5, 
ne can see that for the H/d aspect ratio reported in this work 
104), the calculated Pe was 30, whereas for the reference, the 
e was 44 (with an aspect ratio of 127). However, there were 
wo differences between these two hydrodynamic experiments - 
he VFR resin volume (50 mL and 135 mL) and the type of ad- 
orbents (Streamline rProtein A and Streamline DEAE), which pro- 
uced different expanded bed heights, while the settled bed height 
20 cm), annular gap (0.45 cm) and axial velocity (300 cm/h) were 
he same. Therefore, the difference in the Pe number between the 
wo experiments strongly suggests that the higher the aspect ra- 
io, the greater the number of vortices, thus improving the plug 
ow behavior and the possibility of scaling up the VFR by a factor 
f 2.7. 
According to Curran and Black [42] , the vortex flow reactor used 
s a bioreactor could be successfully scaled up. They selected the 
nnular gap, whereas the Taylor number and L/d were kept con- 
tant. Their research focused on keeping the number of vortices 
airs or mixed tanks constant in the vortex flow reactor. In con- 
rast, the scaling up of the chromatography column is based on 
ncreasing the column diameter while the column’s length and su- 
erficial velocity are kept the same, as are the residence time and 
he theoretical plate number in the column. Thus, the scaling up 
f the vortex flow reactor focused on chromatography should con- 
ider all these parameters. A possible solution would be to choose 
he desired annular gap for the scaling up (increasing the inner 
nd outer cylinders) while keeping the superficial velocity, EB-VFR 
ength, aspect ratio, and Ta/Ta c constant. In this way, the number 
f continuous mixed tanks or theoretical plates in the EB-VFR is 
ept constant. Further research had to be carried out with regard 
o increasing the scaling-up factor. 
The external mass transfer was theoretically compared using 
an ́s correlation for fluidized bed columns [43] and Moore’s Eq. for 
he VFR, at 300 cm/h using Streamline rProtein A as the adsorbent, 
gG2a as the protein and 0.79 as the bed porosity for the culture 
roth. The external mass transfer calculated in the expanded bed 
olumn, 3.7 ·10 −6 (m/s), was higher than the 4.2 ·10 −7 (m/s) for the 
B-VFR and the calculated values in Table 2 . However, Ibáñez and 
ooney [18] obtained better results in the VFR using another pro- 
ein (BSA) and adsorbent (Streamline DEAE), when the ratio be- 
ween the annular gap and the inner cylinder, d/r i, was below 0.2. 
oore’s correlation has two extra variables: the d/r i ratio and the 
otation rate, which can vary the external mass transfer coefficient 
nd improve it. 
The dimensionless Biot number B i = k mf · d p / D p was estimated 
o know if the adsorption process is limited by external mass 
ransfer or by the pore diffusion stage, where d p is the average par- 
icle size (123 μm), and D p (m 2 /s) is the pore diffusion coefficient 
stimated by the following correlation [44] D p = (ε p / 2 − ε p ) 2 · D m , 
 
being the porosity of the solid particles (0.5 was chosen in this 
ork). A Biot number of 11.2 was obtained using the lowest exter- 
al mass transfer coefficient (4.2 ·10 −7 , m/s), which indicates that 
ore diffusion limits the adsorption process. This result agrees with 
he literature data [ 13 , 18 ]. Although the external mass transfer is 
ower in the EB-VFR, the adsorption process is efficient. Even if ex- 
ernal mass transfer limits the adsorption process, the VFR should 
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e built with a d/r i ratio of around 0.2, choosing the highest ro- 
ation rate that admits plug flow behavior, thus ensuring higher 
ass transfer than an expanded bed column. 
The Pèclet number was compared between the expanded bed 
FR ( Table 2 ) and the column. A Pèclet value of 15 was reported
or an expanded bed column using Streamline rProtein A at close 
o 300 cm/h [45] . In this case, higher values were obtained (42- 
4) at 300 cm/h due to the extra variable (the rotation rate). The 
FR has the advantage of the vortices generating a fairly stable ex- 
anded bed. However, it is a challenge to avoid channeling and 
ead spaces in the expanded bed columns with perforated plates 
nd mesh [46] . A better system, namely the rotating fluid distrib- 
tor, was designed by Hubbuch et al. [47] to obtain a stable ex- 
anded bed. Nevertheless, it still needs to use robust particle ad- 
orbents to avoid them being broken by the rotating cylindrical 
istributor blades. In contrast, the vortex flow reactor can work 
ith all kinds of adsorbents designed for expanded beds and at 
ll rotation rates because the vortices generated are softer for the 
article beads. 
.4. IgG2a purification using a vortex flow reactor 
During the adsorption process, 5L of cell culture with an IgG2a 
oncentration of 0.05 mg/mL was introduced under the following 
perating conditions: axial flow rate (300 cm/h), rotation rate (50 7 pm) and rProtein A volume (50 mL); these were chosen based on 
he criteria described below. 
The axial flow rate (300 cm/h) was selected following the sug- 
estion of Thömmes et al. [45] . They employed a minimum flow 
ate, above 300 cm/h, to develop a stable expanded bed column 
or isolating monoclonal antibodies with Streamline rProtein A. 
The inner cylinder’s rotation rate was chosen considering the 
ewtonian behavior of the cell culture’s viscosity. Experiments 
howed a linear relationship between the shear stress and the 
hear rate, with n at around 1. The calculated flow index value was 
.02 and the average viscosity value for different viscometer speeds 
50-90 rpm) was 1.26 mPa ·s. Therefore, the rotation rate does not 
ffect the cell culture viscosity, which remains constant. The mass 
ransfer only increases with an increased rotation rate or increased 
urbulence within or between the vortices. 
One can see from Eq. (4) that the Ta number strongly depends 
n the kinematic viscosity. Consequently, the cell culture density 
as also measured (1150 kg/m 3 ). For the same rotation speed, in- 
reased viscosity can cause the Ta number to drop below the criti- 
al Ta c value at which the vortices regime disappears. The cell cul- 
ure viscosity value is always greater than the water viscosity value 
o an inner cylinder rotation rate above 35 rpm was chosen to es- 
ablish the vortices (in this case 50 rpm), with a Ta number of 118 
nd a Ta/Ta c ratio of 1.5. Likewise, a broth with a higher kinematic 
iscosity could be used, increasing the rotation rate up to a sim- 
lar Ta/Ta c ratio of 1.5. During the adsorption process, the IgG2a 
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Fig. 4. C/Co (Concentration of IgG2a at the outlet divided by the feed concentration) versusthe column volumes (CV) during all the process stages (adsorption and wash at 





































Amount of IgG2a harvested and the yield from the to- 
tal amount introduced for each elution fraction in the 
frontal analysis of the expanded bed column. 
pH ug IgG2a Yield (%) 
6 166.77 10.7 
5 1271.60 81.9 
4 64.72 4.2 
3 48.99 3.2 
All pH 1552.08 100 
Table 4 
Volume, IgG2a amount, and IgG2a yield in each VFR purification step: adsorption 
and wash in EB-VFR, and the elution (pH 5 and 3) in the settled-bed VFR. 
Purification stages Volume (mL) mg IgG2a IgG2a Yield (%) 
Feed 5000 250 100 
Adsorption 5000 0 0 
Wash 250 0 0 
Elution pH5 520 188 75.1 
Elution 2 pH3 370 44.8 17.9 
















oncentrations in the feed and the EB-VFR outlet collecting tubes 
ere determined by Elisa assays. 
The C/Co is the ratio between the IgG2a concentration at the 
FR outlet (C) and the initial feed concentration (Co) during the 
arious stages: the adsorption and wash in the expanded bed and 
he elution in the packed bed. This is represented against the num- 
er of column volumes in Fig. 4 , which refers to the resin volume
50 mL) during the IgG2a purification process. 
Under these operating conditions (Ta/Ta c 1.5 and Re 3.8), one 
ould observe from the visual and hydrodynamic experiments that 
he EB-VFR worked in the laminar vortex regime and behaved as 
 plug flow reactor (the Pe number being between 42 and 44) 
uring the adsorption process. All the IgG2a was adsorbed in the 
esin so the Elisa assay (with a limit of detection below 6.25 ng of 
gG2a/mL) could not detect an IgG2a concentration at the outlet. 
he dynamic capacity, defined as the amount of IgG2a adsorbed 
n a milliliter of resin, was calculated as 5 mg/mL. The productiv- 
ty per cycle was defined as the dynamic capacity per volume of 
esin - a value of 250 mg IgG2a per cycle. The IgG2a adsorption 
n the EB-VFR took eight hours. It would be possible to decrease 
he adsorption time by increasing the IgG2a concentration in the 
eed, which would also increase the dynamic capacity and produc- 
ivity. The height of the expanded bed was 54 cm; hence, under 
he established conditions, the number of vortices along the VFR 
ength was 120 (60 continuous pairs of vortices or mixed tanks), 
hich created a plug flow during the adsorption. Although the cul- 
ure’s density and viscosity values were only slightly higher than 
he physical properties of the equilibrium buffer, the expanded bed 
eight increased by 7 cm during the adsorption stage. This can be 
ttributed to the presence of cells (5 × 10 6 cells/mL) as the ex- 
anded bed height depends on the fluid’s physical properties and 
he particle concentration. After the feed was introduced, equili- 
ration buffer was used to clean the resin contained in the EB-VFR 
ntil no protein or particles were detected. 
A frontal analysis was performed in the expanded bed column 
o determine the elution pH. The bound antibodies (1.5 mg of 
gG2a per 1 mL of resin) were eluted at 150 cm/h with 100 mM of
odium citrate buffer at continuously decreasing pH values, start- 8 ng at pH 6 and ending at pH 3, looking for the highest pH value
o avoid strong neutralization. Table 3 shows the amount eluted at 
ach pH and the percentage of IgG2a recovered with respect to the 
otal amount of IgG2a eluted across all the pH values. The greatest 
mount of IgG2a was eluted at pH 5, so this value, followed by pH 
, was chosen for the elution process. 
During the elution step in the VFR’s settled bed, 188 mg of 
gG2a were obtained at pH 5 (see Table 4 ). The product eluted 
rom the column was more concentrated, more than 7-fold higher 
han the starting material ( Fig. 4 ). The yield was calculated at 75.1
ercent. The top of the peak eluted at pH5 reached a C/C 0 of 30,
orresponding to a recovery of 24.6% and 61.42 mg of IgG2a. The 
ighest concentration achieved in the elution fraction was 1.47 mg 
gG2a/mL. During the elution, 44.8 mg of IgG2a were recovered at 
H 3, which represents 17.9 percent of the initial IgG2a. Between 
he two peaks, an IgG2a yield of 93.1 % was recovered. 
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Fig. 5. SDS-PAGE gel of antibody fractions to evaluate the purity of the IgG2a in the VFR elution step. Lane 1: molecular weight markers, 3-200 kDa; Lane 2: IgG2a antibody 





























































.5. Purity of the eluted fraction 
The results from the Mouse Immunoglobulin Isotyping ELISA 
nalysis of the culture only detected the presence of IgG2a. The 
DS-PAGE analysis ( Fig. 5 ) was carried out to confirm the purity 
f the fractions obtained during the elution step. The fractions ob- 
ained in the elution at pH5 (lanes 3, 4 and 5) were analyzed and
ompared with a pure IgG2a antibody standard and front molec- 
lar weight markers. The SDS-PAGE analysis results showed high 
gG2a purity for the fractions obtained in the elution at pH 5, 
igher for the head and tail than for the peak. Both the Isotyping 
nd the SDS-PAGE analyses, along with the IgG selectivity of the 
Protein A resin, confirmed high IgG2a antibody purity eluted at 
H 5, which can be extrapolated to the eluted IgG2a antibody frac- 
ion at pH 3. In addition, this allowed us to measure the antibodies 
n the elution stage using the standard IgG2a antibody calibration. 
Finally, Table 5 compares the yield and purity achieved in the 
ntibody purification process using the VFR with other technolo- 
ies. Using Protein A in the VFR seems to be a better option for 
btaining highly pure antibodies in a single stage, involving ad- 
orption and elution steps, compared to the other techniques in- 
estigated. González et al. [48] used an expanded bed column with 
rotein A without a prior clarification stage; they achieved a sim- 
lar yield as in our work and a higher purity. However, they con- 
rmed that the presence of DNA, released by the lysed hybridoma 
ells, can block the mesh at the column inlet. In the VFR, this 
rawback is avoided because the inlet is a hole (2 mm in diam- 
ter) that cannot be blocked by the presence of DNA or any other 
mpurity. Also, when the process rate is analyzed, namely the re- 
ationship between the treated feed volume and the total pro- 
ess time (including the adsorption, washing and elution times), 
he VFR device used in this work achieved a process rate (7.4 
l/min) that was three-times higher than that achieved in the 
onzález research, which used expanded bed adsorption technol- 9 gy (2.4 ml/min). Moreover, the VFR process time could be longer 
hen working with more viscous broth - here, the expanded bed 
nd traditional column cannot compete due to blocking issues and 
he high pressure. 
.6. Viability of the expanded bed vortex flow reactor 
The productivity, defined as the number of antibodies per liter 
f resin and per hour (P, g /(h ·L), is calculated using Eq. P = 
 10% / t p , where Q 10% is the dynamic capacity for C/Co = 0.1 and 
 p (h) is the processing time. The productivity of our equipment 
EB-VFR) was compared to a conventional process (a packed-bed 
olumn). In the traditional process, the processing time considers 
oth the clarification time (t c , h) and the affinity chromatography 
ime (t a , h), so t p = t c + t a . In contrast, for EB-VFR, only t p = t a 
eeds to be considered. The polishing stage is not taken into ac- 
ount because it would be the same for both processes, if needed. 
The affinity chromatography time (t a , h) involves the pre- 
onditioning, equilibration, adsorption, wash, elution and regener- 
tion stages. This was calculated using the modified Swinnen Eq. 
50] , t a = Q 10% / C 0 · u a + 22 CV / u a , where the first term is the ad-
orption time. The second term represents the time for the other 
hromatography stages, and 22 CV was assumed for the same axial 
ow rate (u a , CV/h) in the packed bed column. For the EB-VFR, 20 
V was assumed in the second term, where the axial flow rate is 
he same for the equilibration stage (300 cm/h) but lower for the 
lution and regeneration stages in the settled bed (100 cm/h). 
Swinnen et al. [50] compared five protein A affinity resins for 
he purification of monoclonal antibodies. They analyzed the dy- 
amic capacity (Q 10% ) for the upper and lower linear flow rates of 
he resin’s operating range. The cell culture (Co = 0.68 hIgG/L) was 
larified consecutively with a depth filter at 150 L/h ·m 2 (0.027 m 2 
or the lab-scale, as indicated by the manufacturer) and an ab- 
olute 0.22 μm filter (18 mL/min ·cm 2 and a 13 mm diameter, 
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Table 5 
Antibody yield and purification factors from the various purification processes. 
Purification system Steps Procedure Antibody Process yield (%) Purity (%) Reference 
Vortex flow reactor / Protein A Single 1. Vortex flow 
reactor with 
Protein A 
IgG2a 93.1 High Purity This work 
Expanded bed column/ Protein A Single 1. Expanded bed 
with Protein A 
IgG2a 85 High Purity [45] 
Expanded bed column/ Protein A Single 1. Expanded bed 
with Protein A 
IgG2b 92 98 [48] 






IgG 97 95 [28] 




IgG 97.7 82.6 [31] 
Integrated purification platform Multiple 1. Activated carbon 
2. Cation exchange 
chromatography 
3. Anion exchange 
chromatography 
IgG1 > 80 > 98 [49] 
Table 6 
Axial flow rate, dynamic capacity, clarification and chromatography processing times and productivity for 
the different adsorbents from the clarified cell culture in the packed-bed column (0.68 hIgG/L). 
u a 
∗
Adsorbent cm/h CV/h Q 10% 
∗∗(g/L) t c (h) t a (h) Productivity (g/L ·h) 
Prosep vA Ultra resin 500 25.0 43.5 3.4 1.2 9.4 (6.6) 
Prosep A High Capacity 500 25.0 28.6 2.6 0.8 8.6 (6.2) 
MabSelect 300 15.1 40.1 5.4 1.1 6.2 (4.9) 
MabSelect Xtra 200 10.3 60.1 10.7 1.6 4.9 (4.0) 
Rmp Protein A Sepharose 4FF 200 10.3 37.7 7.5 1.0 4.4 (3.7) 
The values in parentheses are the productivity calculated for an adsorbent volume of 50 mL, keeping the 
length (20 cm) and axial flow rate constant. 
∗ Average of the upper and lower axial flow rates [50] . 























































s indicated by the manufacturer). The data from Swinnen et al. 
50] were used to calculate the clarification and the affinity chro- 
atography times, as well as the productivity of these five adsor- 
ents in the packed-bed column, as shown in Table 6 . According to 
he authors, the clarification time increased with an increase in the 
ynamic capacity or the cell-culture volume. In contrast, the chro- 
atography time decreased, while the productivity increased more 
y increasing the axial flow rate than by increasing the dynamic 
apacity. Likewise, the productivity was calculated for 50 mL of 
dsorbent (the data in parentheses in Table 6 ) to compare it with 
B-VFR productivity. The productivity is reduced because of the in- 
rease in the clarification time or the clarified cell-culture volume, 
hereas the chromatography time remains the same. Hence, the 
olumn length and axial flow rate were constant. 
The productivity of the EB-VFR (50 mL of Streamline rProtein 
) was calculated, giving a low value of 0.40 (g/(L ·h). The dynamic 
apacity (5 mg/mL) was obtained at C/Co = 0 instead of C/Co = 0.1 
ue to the antibody concentration being low (0.5 mg IgG2a/L) and 
he adsorption time at 300 cm/h being long (8.1 h); this was the 
ame for the elution time and the regeneration times at 100 cm/h 
4.2 h) in the settled bed with no pressure. This productivity was 
ecalculated for an antibody concentration of 0.68 g/L (to compare 
t with the productivities of the packed-bed adsorbents) and with 
he optimized values reported for Streamline rProtein A and IgG2a 
45] , such as a dynamic capacity of 20 mg IgG2a/mL, an axial flow 
ate of 360 cm/h and an axial elution rate of 150 cm/h. The recal-
ulated productivity increased to 4.0 g/L ·h. The affinity chromatog- 
aphy time for EB-VFR dropped from 12.6 h to 5 h but was far 10 rom the 1 hour (approx.) for protein A adsorbents in the packed 
ed ( Table 6 ). Although EB-VFR productivity could compete against 
he lower axial flow rate adsorbents, it does not do so against the 
igh axial flow rate adsorbent due to the high porosity and pump 
ressure required to maintain the axial flow rate. To improve EB- 
FR productivity, a denser adsorbent is needed to increase the ax- 
al flow rate and to provide greater dynamic capacity. These are 
he so-called second-generation adsorbents [51] . Furthermore, the 
xial flow rate is kept constant in all the stages because in the ex- 
anded bed, the stage performance is around twice that of the set- 
led bed. 
Working at industrial scale, 20 0 0 L per batch, the packed col- 
mn is made up of 14.5 L of adsorbent [52] . At this scale, columns
hat have a diameter above 30 cm suffer from packing problems 
hat lead to resin compression, edge effect and hysteresis, where 
ead spaces and different flow rates are created in the column 
53] . Moreover, the clarification stage takes eight hours, assuming 
ouble filtration [52] ; this is in addition to the considerable in- 
estment required, the complicated maintenance and the absolute 
ltration working at pressure. These limitations are even greater 
hen the cell broth is viscous. According to the information re- 
orted by Chahar et al. [54] , the clarification stage involves costs 
anging from 7,0 0 0 – 12,0 0 0 US$ per batch as well as the use of
angential flow filtration, costing 1,500 US$ per m 2 . Therefore, us- 
ng EB-VFR with second-generation adsorbents is an attractive op- 
ion at the industrial scale, as it avoids these costs and any pack- 
ng issues. Consequently, future research should focus on scaling- 
p this process to make it competitive. 





































































The vortex flow reactor, operating with laminar vortices (with 
 drift velocity of 1.2) and plug flow hydrodynamic behavior, 
an successfully purify IgG2a antibodies from unclarified culture. 
he purification process was carried out employing a single de- 
ice under very unfavorable conditions, with an unclarified cul- 
ure broth that had a high impurities content and a low anti- 
ody concentration. This technology has overcome the blockage 
ssue, obtaining a high IgG2a yield, seven times more concen- 
rated than in the starting material and with a high purity, as 
emonstrated by the SDS-PAGE gel assessment. The adsorption 
nit in an expanded-bed vortex flow reactor is the only opera- 
ional step required in the process, provided that the adsorbent 
rProtein A) exhibits selectivity for the monoclonal antibody of 
nterest. Prior filtration and biomolecule concentration stages are 
liminated, leaving a very simple process flow chart employing 
 single device. Although Protein A adsorbents in packed beds 
ave been improved to provide a high axial flow rate and high 
ynamic capacity, EB-VFR using second-generation expanded-bed 
dsorbents offers a good alternative as it avoids the packing is- 
ues at large scale as well as the costly investment and mainte- 
ance required for the clarification stage. Working with extracel- 
ular biomolecules makes the purification process more competi- 
ive than purifying intracellular biomolecules, or traditional biopro- 
esses that need more stages and processing time. The benefits of 
he vortex flow reactor provide a reliable and effective alternative 
o the extracellular biomolecule purification process. In addition, 
t could be considered as a promising prior step to the polishing 
rocess. Nonetheless, future research should focus on developing 
ompetitive expanded-bed adsorbents (denser and higher dynamic 
apacity than packed-bed adsorbents) and scaling-up the EB-VFR 
rocess. 
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